These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24085772)

  • 1. The national drug abuse treatment clinical trials network data share project: website design, usage, challenges, and future directions.
    Shmueli-Blumberg D; Hu L; Allen C; Frasketi M; Wu LT; Vanveldhuisen P
    Clin Trials; 2013; 10(6):977-86. PubMed ID: 24085772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data management in substance use disorder treatment research: Implications from data harmonization of National Institute on Drug Abuse-funded randomized controlled trials.
    Susukida R; Amin-Esmaeili M; Mayo-Wilson E; Mojtabai R
    Clin Trials; 2021 Apr; 18(2):215-225. PubMed ID: 33258697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.
    Tross S; Campbell AN; Calsyn DA; Metsch LR; Sorensen JL; Shoptaw S; Haynes L; Woody GE; Malow RM; Brown LS; Feaster DJ; Booth RE; Mandler RN; Masson C; Holmes BW; Colfax G; Brooks AJ; Hien DA; Schackman BR; Korthuis PT; Miele GM;
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):283-93. PubMed ID: 21854270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying and responding to trial implementation challenges during multisite clinical trials.
    Greer TL; Walker R; Rethorst CD; Northrup TF; Warden D; Horigian VE; Silverstein M; Shores-Wilson K; Stotts AL; Trivedi MH
    J Subst Abuse Treat; 2020 Mar; 112S():63-72. PubMed ID: 32220413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network.
    Marsch LA; Campbell A; Campbell C; Chen CH; Ertin E; Ghitza U; Lambert-Harris C; Hassanpour S; Holtyn AF; Hser YI; Jacobs P; Klausner JD; Lemley S; Kotz D; Meier A; McLeman B; McNeely J; Mishra V; Mooney L; Nunes E; Stafylis C; Stanger C; Saunders E; Subramaniam G; Young S
    J Subst Abuse Treat; 2020 Mar; 112S():4-11. PubMed ID: 32220409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assurance of research protocols conducted in the community: the National Institute on Drug Abuse Clinical Trials Network experience.
    Rosa C; Campbell A; Kleppinger C; Sampson R; Tyson C; Mamay-Gentilin S
    Clin Trials; 2009 Apr; 6(2):151-61. PubMed ID: 19342468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between Clinical Trial Network protocol involvement and quality of substance use disorder treatment.
    Abraham AJ; Knudsen HK; Roman PM
    J Subst Abuse Treat; 2014 Feb; 46(2):232-7. PubMed ID: 24080073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partnerships and pathways of dissemination: the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network.
    Martino S; Brigham GS; Higgins C; Gallon S; Freese TE; Albright LM; Hulsey EG; Krom L; Storti SA; Perl H; Nugent CD; Pintello D; Condon TP
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S31-43. PubMed ID: 20307793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A centralized informatics infrastructure for the National Institute on Drug Abuse Clinical Trials Network.
    Pan JJ; Nahm M; Wakim P; Cushing C; Poole L; Tai B; Pieper CF
    Clin Trials; 2009 Feb; 6(1):67-75. PubMed ID: 19254937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: a summary of findings.
    Greenfield SF; Rosa C; Putnins SI; Green CA; Brooks AJ; Calsyn DA; Cohen LR; Erickson S; Gordon SM; Haynes L; Killeen T; Miele G; Tross S; Winhusen T
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):301-12. PubMed ID: 21854272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network.
    Lindblad R; Hu L; Oden N; Wakim P; Rosa C; VanVeldhuisen P
    J Subst Abuse Treat; 2016 Nov; 70():73-80. PubMed ID: 27692192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing ethnic minority participation in substance abuse clinical trials: lessons learned in the National Institute on Drug Abuse's Clinical Trials Network.
    Burlew K; Larios S; Suarez-Morales L; Holmes B; Venner K; Chavez R
    Cultur Divers Ethnic Minor Psychol; 2011 Oct; 17(4):345-56. PubMed ID: 21988575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection.
    Potter JS; Donovan DM; Weiss RD; Gardin J; Lindblad R; Wakim P; Dodd D
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):400-7. PubMed ID: 21854283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network.
    Campbell AN; Nunes EV; Miele GM; Matthews A; Polsky D; Ghitza UE; Turrigiano E; Bailey GL; VanVeldhuisen P; Chapdelaine R; Froias A; Stitzer ML; Carroll KM; Winhusen T; Clingerman S; Perez L; McClure E; Goldman B; Crowell AR
    Contemp Clin Trials; 2012 Mar; 33(2):386-95. PubMed ID: 22085803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network.
    Roman PM; Abraham AJ; Rothrauff TC; Knudsen HK
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1():S44-52. PubMed ID: 20307795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. User-Friendly Data-Sharing Practices for Fostering Collaboration within a Research Network: Roles of a Vanguard Center for a Community-Based Study.
    Lee JE; Sung JH; Barnett ME; Norris K
    Int J Environ Res Public Health; 2015 Dec; 13(1):ijerph13010034. PubMed ID: 26703645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blending research and practice: an evolving dissemination strategy in substance abuse.
    Michel ME; Pintello DA; Subramaniam G
    Soc Work Public Health; 2013; 28(3-4):302-12. PubMed ID: 23731421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and promotion of a national website to improve dissemination of information related to the prevention of mother-to-child HIV transmission (PMTCT) in Tanzania.
    Stephan G; Hoyt MJ; Storm DS; Shirima S; Matiko C; Matechi E
    BMC Public Health; 2015 Oct; 15():1077. PubMed ID: 26494170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.